ATE410428T1 - Pyrroloä2,1-cüä1,4übenzodiazepine als vasopressin-agonisten - Google Patents
Pyrroloä2,1-cüä1,4übenzodiazepine als vasopressin-agonistenInfo
- Publication number
- ATE410428T1 ATE410428T1 AT03814820T AT03814820T ATE410428T1 AT E410428 T1 ATE410428 T1 AT E410428T1 AT 03814820 T AT03814820 T AT 03814820T AT 03814820 T AT03814820 T AT 03814820T AT E410428 T1 ATE410428 T1 AT E410428T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrroloä2
- cüä1
- vasopressin agonists
- vasopressin
- agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/320,761 US7138393B2 (en) | 1998-07-24 | 2002-12-16 | Biologically active vasopressin agonist metabolites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410428T1 true ATE410428T1 (de) | 2008-10-15 |
Family
ID=32710746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03814820T ATE410428T1 (de) | 2002-12-16 | 2003-12-16 | Pyrroloä2,1-cüä1,4übenzodiazepine als vasopressin-agonisten |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7138393B2 (de) |
| EP (1) | EP1572694B1 (de) |
| JP (1) | JP2006514956A (de) |
| CN (1) | CN1745083A (de) |
| AR (1) | AR042467A1 (de) |
| AT (1) | ATE410428T1 (de) |
| AU (1) | AU2003297127A1 (de) |
| BR (1) | BR0317383A (de) |
| CA (1) | CA2508764A1 (de) |
| DE (1) | DE60324018D1 (de) |
| DK (1) | DK1572694T3 (de) |
| ES (1) | ES2312859T3 (de) |
| MX (1) | MXPA05006241A (de) |
| TW (1) | TW200413355A (de) |
| WO (1) | WO2004060894A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| RU2472539C2 (ru) | 2007-08-06 | 2013-01-20 | Аллерган, Инк. | Способы и устройства для доставки препарата десмопрессина |
| US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
| US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
| LT3225249T (lt) | 2008-05-21 | 2019-01-10 | Ferring B.V. | Burnoje disperguojamas desmopresinas, skirtas pirminio miego periodo, nepertraukiamo nikturija, pailginimui |
| EP2358714B1 (de) * | 2008-11-18 | 2012-08-01 | F. Hoffmann-La Roche AG | Alkylcyclohexylether von dihydrotetraazabenzoazulenen |
| US9532959B2 (en) | 2010-07-08 | 2017-01-03 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US10010514B2 (en) | 2010-07-08 | 2018-07-03 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| US10105330B2 (en) | 2012-01-04 | 2018-10-23 | Wellesley Pharmaceuticals, Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
| KR20180023057A (ko) * | 2012-01-04 | 2018-03-06 | 웰즐리 파마슈티컬스 엘엘씨 | 배뇨 빈도를 감소시키기 위한 서방형 제제 및 이의 사용 방법 |
| AU2012363789B2 (en) * | 2012-01-04 | 2017-04-13 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US10278925B2 (en) | 2012-01-04 | 2019-05-07 | Wellesley Pharmaceuticals, Llc | Delayed-release formulations, methods of making and use thereof |
| US10105328B2 (en) | 2014-06-06 | 2018-10-23 | Wellesley Pharmaceuticals, Llc | Composition for reducing frequency of urination, method of making and use thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1251767B (de) | 1964-02-28 | 1968-04-18 | Dr Karl Thomae Gesellschaft mit beschrankter Haftung Biberach/Riß | Verfahren zur Herstellung von neuen m 6 Stellung substituierten 5 6 Dihydro-5oxo HH pyrido[2,3-b] [l,5]benzodiazepinen |
| US4680298A (en) | 1983-05-31 | 1987-07-14 | Schering Corporation | Tricyclic anti-allergy and use as anti-inflammatory agents |
| US4766108A (en) | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
| US5055448A (en) | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
| US4839355A (en) | 1987-09-09 | 1989-06-13 | Sterling Drug Inc. | Tricyclic-pyridinylquinoline compounds, their preparation and use |
| US5070187A (en) | 1989-11-03 | 1991-12-03 | Trustees Of Boston University | Pharmacologically effective antagonists of arginine-vasopressin |
| CA2048003A1 (en) | 1990-08-21 | 1992-02-22 | Serge Burner | Tricyclic pyridone derivatives |
| US5516774A (en) | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5512563A (en) | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5420270A (en) | 1993-10-07 | 1995-05-30 | G. D. Searle & Co. | Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| DE69535486T2 (de) | 1994-06-15 | 2008-04-10 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclische Verbindungen verwendbar als Vasopressin- oder Oxytocin-Modulatoren |
| JPH0881460A (ja) | 1994-09-08 | 1996-03-26 | Yamanouchi Pharmaceut Co Ltd | 新規なテトラヒドロベンゾジアゼピン誘導体又はその塩 |
| AR002459A1 (es) | 1995-01-17 | 1998-03-25 | American Cyanamid Co | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion. |
| US5536718A (en) | 1995-01-17 | 1996-07-16 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5521173A (en) | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
| TW359669B (en) | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
| US5880122A (en) | 1996-11-01 | 1999-03-09 | American Home Products Corporation | 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines |
| AU727654B2 (en) | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
| ATE277050T1 (de) | 1997-07-30 | 2004-10-15 | Wyeth Corp | Trizyclische vasopressin agoniste |
| AU2607300A (en) | 1999-02-04 | 2000-08-25 | American Home Products Corporation | Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
| US6297234B1 (en) | 1999-02-04 | 2001-10-02 | American Home Products Corporation | Arylthiophene vasopressin agonists |
| AU7716100A (en) | 1999-09-27 | 2001-04-30 | American Cyanamid Company | Pharmaceutical carrier formulation |
| MXPA02003191A (es) | 1999-09-27 | 2002-09-30 | American Cyanamid Co | Formulacion agonista de vasopresina y proceso para elaborar la misma. |
| GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
| GB0015601D0 (en) | 2000-06-26 | 2000-08-16 | Ferring Bv | Novel antidiuretic agents |
-
2002
- 2002-12-16 US US10/320,761 patent/US7138393B2/en not_active Expired - Fee Related
-
2003
- 2003-12-09 TW TW092134683A patent/TW200413355A/zh unknown
- 2003-12-15 AR ARP030104629A patent/AR042467A1/es not_active Application Discontinuation
- 2003-12-16 JP JP2004565510A patent/JP2006514956A/ja active Pending
- 2003-12-16 BR BR0317383-6A patent/BR0317383A/pt not_active IP Right Cessation
- 2003-12-16 DK DK03814820T patent/DK1572694T3/da active
- 2003-12-16 DE DE60324018T patent/DE60324018D1/de not_active Expired - Lifetime
- 2003-12-16 WO PCT/US2003/039897 patent/WO2004060894A1/en active Application Filing
- 2003-12-16 AT AT03814820T patent/ATE410428T1/de not_active IP Right Cessation
- 2003-12-16 CA CA002508764A patent/CA2508764A1/en not_active Abandoned
- 2003-12-16 ES ES03814820T patent/ES2312859T3/es not_active Expired - Lifetime
- 2003-12-16 AU AU2003297127A patent/AU2003297127A1/en not_active Withdrawn
- 2003-12-16 EP EP03814820A patent/EP1572694B1/de not_active Expired - Lifetime
- 2003-12-16 MX MXPA05006241A patent/MXPA05006241A/es active IP Right Grant
- 2003-12-16 CN CNA2003801095935A patent/CN1745083A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1745083A (zh) | 2006-03-08 |
| CA2508764A1 (en) | 2004-07-22 |
| WO2004060894A1 (en) | 2004-07-22 |
| US7138393B2 (en) | 2006-11-21 |
| TW200413355A (en) | 2004-08-01 |
| AR042467A1 (es) | 2005-06-22 |
| AU2003297127A1 (en) | 2004-07-29 |
| US20030134845A1 (en) | 2003-07-17 |
| EP1572694B1 (de) | 2008-10-08 |
| DK1572694T3 (da) | 2009-02-02 |
| ES2312859T3 (es) | 2009-03-01 |
| JP2006514956A (ja) | 2006-05-18 |
| DE60324018D1 (de) | 2008-11-20 |
| BR0317383A (pt) | 2005-11-16 |
| MXPA05006241A (es) | 2005-08-19 |
| EP1572694A1 (de) | 2005-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50304983D1 (de) | Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren | |
| DE60330694D1 (de) | Pyrimidopyrimidone als kinaseinhibitoren | |
| DE60308850D1 (de) | Pyridinoylpiperidine als 5-ht1f agonisten | |
| ATE525377T1 (de) | Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase | |
| DE602004012154D1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamine als pde-2-inhibitoren | |
| NO20053248D0 (no) | Kerosenblanding. | |
| DE60308670D1 (de) | Substituierte indole als alpha-1 agonisten | |
| NO20052248D0 (no) | Svivelstykkesystem. | |
| DE60305332D1 (de) | IMIDAZOi1,2-AöPYRIDINE | |
| NO20051500D0 (no) | Substituerte heterocyklylpyrimidiner. | |
| ATE410428T1 (de) | Pyrroloä2,1-cüä1,4übenzodiazepine als vasopressin-agonisten | |
| NL1027545A1 (nl) | Chinolonen als antibacteriele middelen. | |
| DE602004004295D1 (de) | 6-ä(substituiertes)phenylütriazolopyrimidine als antikrebsmittel | |
| NO20051497D0 (no) | Beta-laktamaseinhibitorprodrug. | |
| NL1024983A1 (nl) | Morfolinen als dopamineagonisten. | |
| ITMI20032170A1 (it) | Tagliacimosse. | |
| ITMI20030365A1 (it) | Filatoio. | |
| ITMI20030916A1 (it) | Lancetta. | |
| ATE491683T1 (de) | Muskarine agonisten | |
| ES1055317Y (es) | Escenario autotransportable. | |
| ES1052590Y (es) | Quiosco-consigna. | |
| ES1051283Y (es) | Portabalas multicalibres. | |
| ITDP20020008U1 (it) | Portacono salvagoccia. | |
| ES1052628Y (es) | Extintor instantaneo. | |
| NL1020707A1 (nl) | Houdersamenstel. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |